Phthalazine PDE IV inhibitors: Conformational study of some 6-methoxy-1,4-disubstituted derivatives
- 1 July 2005
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 13 (14) , 4425-4433
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- Phthalazine PDE4 inhibitors. Part 3: The synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptorBioorganic & Medicinal Chemistry Letters, 2002
- PDE4 inhibitors 2001. Patent and literature activity 2000 - September 2001Expert Opinion on Therapeutic Patents, 2002
- Update on the therapeutic potential of PDE4 inhibitorsExpert Opinion on Investigational Drugs, 2002
- Phthalazine PDE4 inhibitors. Part 2: The synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivativesBioorganic & Medicinal Chemistry Letters, 2001
- The therapeutic potential of PDE4 inhibitorsExpert Opinion on Investigational Drugs, 1999
- Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma AgentsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- 3,5-Dichloro-4-pyridinecarbonitrile as a Key Reagent in a Synthesis of Copper Containing Amine Oxidase InhibitorsHETEROCYCLES, 1995
- Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor systemProteins: Structure, Function, and Bioinformatics, 1988
- XXVII.—Synthesis of 3 : 10-dimethoxytetrahydroprotoberberineJournal of the Chemical Society (Resumed), 1929